Compare Tango Therapeutics Inc. (TNGX) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs United Parcel Service Inc — how do they compare? Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B), while United Parcel Service Inc trades at $95.63 (market cap $80.65B). The key difference: United Parcel Service Inc is far larger — about 21.5× Tango Therapeutics Inc.'s market cap, and United Parcel Service Inc pays a 6.92% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and United Parcel Service Inc for 141 Days on average.
| TNGX | UPS | |
|---|---|---|
Market Cap | $3.75B | $80.65B |
Volume | 9,619,106 | 3,099,263 |
Sector | Health | Industrials |
52-Week High | $32.90 | $120.00 |
52-Week Low | $7.50 | $84.09 |
Typical Hold Time | 0 Days | 141 Days |
Enterprise Value | $2.77B | $104.67B |
Dividend Yield | — | 6.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
UPS stock trades at $95.77, up 0.45% on the day, with a bullish technical signal despite mixed moving averages. The company shows consistent earnings beats, with Q3 2026 results pending, and maintains solid profitability with a 5.08% net margin and 29.66% ROE. Recent news highlights strategic moves like the TikTok Shop partnership and Secure Commerce platform launch to bolster e-commerce security and margins.
The outlook is cautiously optimistic, supported by analyst consensus of $118.67 price target and 46.7% buy ratings, but risks include declining revenue trends, competitive pressures from Amazon, and fuel cost volatility. The stock's 7% dividend yield offers income appeal, though margin sustainability remains a key watchpoint for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
